The event will focus on EscharEx, an innovative biologic drug in late-stage development for chronic wound debridement, specifically targeting Venous Leg Ulcers (VLUs). The event will feature three ...
Innovations in wound care technology and the development of new drug formulations and medical devices are enhancing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results